Submissions
Submission Preparation Checklist
Before completing the submission, authors are asked to confirm the following:
I confirm that this submission is original work, or that all third-party ideas, text, images, data, and materials have been properly acknowledged.
I confirm that this manuscript is not currently under consideration elsewhere, or, if there is any related circumstance, it has been fully disclosed to the editors.
I confirm that the submission falls within the scope of the journal and has scholarly, educational, or research-development value.
I confirm that the manuscript has been prepared in an appropriate academic format, and that headings, tables, figures, notes, and references are presented consistently.
I confirm that the manuscript is clearly organized, professionally formatted, and has been checked for language, spelling, and punctuation as far as possible.
I confirm that all listed authors are aware of and agree to this submission.
I confirm that the author names, affiliations, contact information, and other submission details are accurate.
I confirm that all relevant funding sources, conflicts of interest, ethics approvals, or related declarations have been disclosed where applicable.
I confirm that permission has been obtained where necessary for any copyrighted or third-party material included in the submission.
I confirm that, if anonymous review is required, I have uploaded a version of the manuscript with identifying information removed.
I confirm that I understand the journal welcomes diverse forms of scholarly writing, but still requires clarity, consistency, proper formatting, and academic integrity.
投稿檢查清單
作者在正式投稿前，請確認以下事項：
本人確認此稿件為原創作品，或已清楚標示與說明任何使用之他人資料、圖像、文字或研究成果。
本人確認此稿件未同時投稿於其他期刊，或如有相關情況，已於投稿說明中完整告知編輯部。
本人確認稿件主題符合本刊範圍，並具備學術、教育或研究發展意義。
本人確認稿件已依適當學術格式整理，內文、標題、圖表、註釋與參考文獻格式前後一致。
本人確認稿件排版整齊、語句可讀，並已盡可能校對語言、拼寫與標點。
本人確認所有作者均已知悉並同意投稿。
本人確認作者姓名、機構、聯絡方式與其他投稿資訊填寫正確。
本人確認已揭露資金來源、利益衝突、倫理審查或其他需說明之事項。
本人確認如有使用第三方圖像、表格、量表、資料集或其他受保護內容，已取得必要授權或符合法律與學術使用規範。
本人確認若本刊要求匿名審查，已提交不含身份資訊之匿名稿件版本。
本人確認理解本刊鼓勵多元化寫作與學術形式，但仍要求結構清楚、格式規範與學術誠信。
Original Article
This section publishes full-length reports of original research in biomedical science, clinical investigation, public health, bioengineering, and related areas. Manuscripts should present novel findings, sound methodology, appropriate analysis, and clear discussion of the implications and limitations of the work.
Review
This section publishes comprehensive, critical, and balanced overviews of established or rapidly developing topics in biomedicine and related interdisciplinary fields. Submissions should synthesize the current state of knowledge, identify gaps or controversies, and provide scholarly insight of value to researchers, educators, and young investigators. Reviews should be evidence-based and appropriately referenced.
Mini Review
This section publishes concise, focused reviews on emerging topics, new concepts, or narrowly defined areas of biomedical significance. Mini Reviews should provide a timely summary of recent developments while maintaining critical analysis and clarity for a broad scholarly readership.
Letter
This section publishes short scholarly communications, including comments on previously published work, concise observations, preliminary arguments of broad interest, or responses relevant to biomedical research and academic dialogue. Letters should be rigorous, clearly argued, and supported where appropriate.
Brief Communication
This section publishes short reports of original findings, methodological advances, pilot data, or narrowly scoped studies that are scientifically sound and of timely interest but do not require a full-length article format. Submissions should present clear evidence and concise interpretation.
Perspective
This section publishes forward-looking scholarly viewpoints on scientific trends, research culture, education, innovation, ethics, or the future direction of biomedical fields. Perspectives should present a well-reasoned argument grounded in evidence, experience, or emerging developments, and may be especially valuable for highlighting issues relevant to young researchers.
Comment
This section publishes concise opinion or discussion pieces addressing current issues in biomedical science, publishing, education, mentoring, or research practice. Comments should stimulate constructive scholarly discussion and may address policy, interpretation, or broader implications of ongoing developments.
Data Report
This section publishes descriptions of valuable biomedical datasets, including their generation, structure, quality control, accessibility, and potential reuse. Data Reports should prioritize transparency, reproducibility, and utility to the scientific community, even where extensive hypothesis-driven analysis is not the main focus.
Protocol
This section publishes detailed experimental, analytical, clinical, or educational protocols that are sufficiently clear to support reproducibility and adaptation by other researchers. Protocols should describe rationale, materials, procedures, quality control measures, limitations, and, where relevant, validation or troubleshooting guidance.
Republication Study
This section publishes studies that republish, revisit, or re-analyze important findings, datasets, methods, or scholarly materials in ways that improve accessibility, transparency, reproducibility, or interpretive clarity. Submissions should clearly state the rationale for republication, document permissions where required, and explain the scholarly value added by the new presentation or analysis.
Null Results Study
This section publishes scientifically rigorous studies that report negative, null, or non-confirmatory findings of clear methodological quality and scholarly relevance. The journal welcomes such contributions in order to reduce publication bias, support transparent science, and encourage accurate knowledge construction among researchers, especially early-career investigators.
Editorial
This section publishes editorials written or commissioned by the Editors-in-Chief, Editorial Board members, or invited contributors. Editorials may introduce journal aims, highlight thematic priorities, discuss publishing values, or address issues of importance to the journal community.
Copyright Notice
Submitting authors are responsible for ensuring that the manuscript is an original work of the author or authors, and that the content is accurate, lawful, and presented with academic integrity. Authors must ensure that the submission does not infringe the copyright, privacy, data rights, moral rights, or other legitimate interests of any third party.
Authors are responsible for ensuring that:
All quotations, paraphrased material, data, figures, tables, and other borrowed content are properly acknowledged.
Any material requiring permission has been used with appropriate authorization.
Any submission involving participant data, case details, personal information, images, or other sensitive material has been handled in accordance with applicable legal, ethical, and scholarly standards.
All co-authors are aware of and agree to the submission and any later publication arrangements.
Unless otherwise specified by the journal, copyright and licensing arrangements between the author and the journal will be clarified prior to publication in accordance with journal policy. If the journal publishes content on an open access basis, the relevant licensing and reuse terms will be clearly stated on the journal website and article pages.
By completing the submission, the author confirms that they have read and agreed to the relevant copyright and publication policies of the journal.
投稿作者應保證其稿件為本人或共同作者之原創成果，並對內容之真實性、準確性、完整性與合法性負責。作者應確保稿件未侵犯任何第三方之著作權、人格權、資料權、隱私權或其他合法權益。
作者應對下列事項負責：
所有引用、轉述、資料、圖像、表格及其他他人內容均已適當標示來源。
所有需要授權之內容均已取得合法許可。
稿件如使用受試者資料、病例資訊、個人資料、圖片或其他敏感內容，已依適用法律、倫理與學術規範處理。
稿件如涉及共同作者，所有作者均已知悉並同意投稿及後續出版安排。
除本刊另有明確規定外，作者與本刊之間的版權與授權安排，應於錄用與出版前由期刊政策進一步說明。若本刊採開放取用模式，相關授權條款與再利用規則將於網站及文章頁面中明確標示。
作者完成投稿，即表示其已閱讀並同意本刊之相關版權與出版政策。
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
